Copyrigt: private
Dr. Shambhabi Chatterjee, Institute of Molecular and Translational Therapy Strategies, was awarded the "Poster Award 2025" for her poster presentation "Telomerase modRNA therapy confers anti-fibrotic and anti-senescent effects against human pulmonary fibrosis" at the second Fraunhofer CIMD Symposium "RNA-Based Therapeutics 2025" in Hanover in September.
Text: Bettina Dunker